GUTSEER
LIVE

Serial Number

79382092

Owner

SINGLERA GENOMICS (CHINA) LTD.

Attorney

Timothy T. Wang

Filing Date

Jul 17, 2023

Add to watchlist:

No watchlists yet
View on USPTO

GUTSEER Trademark

Serial Number: 79382092 • Registration: 7691245

GUTSEER is a trademark filed by SINGLERA GENOMICS (CHINA) LTD. on July 17, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 37 (Building & Construction), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

SINGLERA GENOMICS (CHINA) LTD. (19 trademarks)

No. 6 Yikang Road,Road,

Entity Type: 03

Trademark Details

Filing Date

July 17, 2023

Registration Date

February 18, 2025

Published for Opposition

December 31, 2024

Goods & Services

Medical clinic services; medical screening; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical assistance; advisory services related to health; medical equipment rental; rental of sanitary installations; nutritional guidance related to diet; sanatorium services; providing cancer screening services

bioreactors for cell culturing for scientific research

publication of books; on-line publication of electronic books and journals; organization of exhibitions for cultural or educational purposes; mobile library services

Retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; advertising services; organization of exhibitions for commercial or advertising purposes; marketing services; import-export agency services; systemization of information into computer databases; provision of an on-line marketplace for buyers and sellers of goods and services; sponsorship search

Medicines for human purposes, namely, medicines for gene therapy and cancer diseases; pharmaceutical preparations for the treatment of gene and cancer diseases; diagnostic preparations for medical purposes; biological preparations for the treatment of cancer, gene therapy, and genetic testing; chemical preparations for the treatment of cancer, gene therapy, and genetic testing; depuratives for the body; diagnostic preparations for veterinary purposes; pesticides; medical dressings; dietetic substances adapted for medical purposes, namely, dietetic preparations adapted for medical purposes

tomographs for medical purposes; surgical apparatus and instruments; apparatus for DNA and RNA exams for medical purposes; biomagnetic rings for therapeutic or medical purposes; surgical implants comprised of artificial materials; suture materials

installation, maintenance and repair of computer hardware; machinery installation, maintenance and repair; sterilization of medical instruments; upholstering

Technological research in the field of cancer disease, gene expression, genetic testing, gene therapy, gene editing technology and related medicines; scientific research in the nature of conducting clinical trials for others in the field of cancer disease, gene expression, genetic testing, gene therapy, gene editing technology and related medicines; biological research; bacteriological research; medical research; medical research, namely, cancer research for medical purposes; platform as a service (PAAS) featuring computer software platforms for use in medical diagnosis and analysis; chemical analysis; culturing of cells for others for scientific research purposes; genetic testing for scientific research purposes

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 19, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 31, 2025 FICS
FINAL DISPOSITION PROCESSED
Aug 31, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 18, 2025 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 19, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 31, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 31, 2025 OPNR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 18, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 18, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 31, 2024 NPUB
PUBLISHED FOR OPPOSITION
Dec 31, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 25, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 7, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 29, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 26, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Nov 26, 2024 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 11, 2024 GNFN
FINAL REFUSAL E-MAILED
Nov 11, 2024 GNFR
FINAL REFUSAL WRITTEN
Nov 11, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 16, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 15, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 15, 2024 TROA
REFUSAL PROCESSED BY IB
May 14, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 19, 2024 RFCS
REFUSAL PROCESSED BY MPU
Apr 19, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 2, 2024 RFCR
NON-FINAL ACTION WRITTEN
Apr 1, 2024 CNRT
ASSIGNED TO EXAMINER
Mar 22, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 11, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 7, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 2, 2023 REPR